Techno Medical Current Valuation vs. Revenue
| TM Stock | THB 1.10 0.04 3.77% |
For Techno Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Techno Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Techno Medical Public utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Techno Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Techno Medical Public over time as well as its relative position and ranking within its peers.
Techno |
Techno Medical Public Revenue vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Techno Medical's current stock value. Our valuation model uses many indicators to compare Techno Medical value to that of its competitors to determine the firm's financial worth. Techno Medical Public is currently regarded number one company in current valuation category among its peers. It also is currently regarded number one company in revenue category among its peers totaling about 0.67 of Revenue per Current Valuation. The ratio of Current Valuation to Revenue for Techno Medical Public is roughly 1.48 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Techno Medical's earnings, one of the primary drivers of an investment's value.Techno Current Valuation vs. Competition
Techno Medical Public is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Industrials industry is at this time estimated at about 1.47 Trillion. Techno Medical adds roughly 998.97 Million in current valuation claiming only tiny portion of equities under Industrials industry.
Techno Revenue vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Techno Medical |
| = | 998.97 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Techno Medical |
| = | 674.15 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Techno Revenue vs Competition
Techno Medical Public is currently regarded number one company in revenue category among its peers. Market size based on revenue of Industrials industry is at this time estimated at about 830.74 Billion. Techno Medical adds roughly 674.15 Million in revenue claiming only tiny portion of equities under Industrials industry.
Techno Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Techno Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Techno Medical will eventually generate negative long term returns. The profitability progress is the general direction of Techno Medical's change in net profit over the period of time. It can combine multiple indicators of Techno Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Techno Medical Public Company Limited trades in medical supplies, tools, and equipment in Thailand. Techno Medical Public Company Limited is based in Bangkok, Thailand. TECHNO MEDICAL operates under Medical Distribution classification in Thailand and is traded on Stock Exchange of Thailand.
Techno Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Techno Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Techno Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Techno Medical's important profitability drivers and their relationship over time.
Use Techno Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Techno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Techno Medical will appreciate offsetting losses from the drop in the long position's value.Techno Medical Pair Trading
Techno Medical Public Pair Trading Analysis
The ability to find closely correlated positions to Techno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Techno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Techno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Techno Medical Public to buy it.
The correlation of Techno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Techno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Techno Medical Public moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Techno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Techno Medical position
In addition to having Techno Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Disruptive Technologies Thematic Idea Now
Disruptive Technologies
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 64 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Techno Stock
To fully project Techno Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Techno Medical Public at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Techno Medical's income statement, its balance sheet, and the statement of cash flows.